Endurance Motive SA
MAD:END
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Endurance Motive SA
MAD:END
|
ES |
|
M
|
Marrone Bio Innovations Inc
F:0MB
|
US |
|
UnipolSai Assicurazioni SpA
MIL:US
|
IT |
|
K
|
Kforce Inc
F:ROF
|
US |
|
Carriage Services Inc
NYSE:CSV
|
US |
|
L
|
Lotus Bio-Technology Development Corp
OTC:LBTD
|
HK |
|
Altron Ltd
F:RY7A
|
ZA |
|
I
|
Innovation Beverage Group Ltd
NASDAQ:IBG
|
AU |
|
H
|
Hyundai Bioscience Co Ltd
KOSDAQ:048410
|
KR |
|
B
|
Belon OAO
MOEX:BLNG
|
RU |
|
K
|
Keemo Fashion Group Ltd
OTC:KMFG
|
CN |
|
V
|
Vilmorin & Cie SA
PAR:RIN
|
FR |
|
Power Corporation of Canada
TSX:POW
|
CA |
|
R
|
Rusta AB (publ)
STO:RUSTA
|
SE |
|
DocuSign Inc
NASDAQ:DOCU
|
US |
|
Taysha Gene Therapies Inc
NASDAQ:TSHA
|
US |
|
Qube Holdings Ltd
ASX:QUB
|
AU |
|
Preferred Bank
NASDAQ:PFBC
|
US |
|
enCore Energy Corp
XTSX:EU
|
CA |
|
Eukedos SpA
MIL:EUK
|
IT |
|
D
|
Dialog Group Bhd
KLSE:DIALOG
|
MY |
|
Franklin BSP Capital Corp
OTC:FRBP
|
US |
|
Compass Pathways PLC
NASDAQ:CMPS
|
UK |
|
Ford Otomotiv Sanayi AS
IST:FROTO.E
|
TR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is END's stock price target?
Not Available
END doesn't have any price targets made by Wall Street professionals.
What is Endurance Motive SA's Revenue forecast?
Projected CAGR
63%
For the last 4 years the
compound annual growth rate for
Endurance Motive SA's revenue is
29%.
The projected
CAGR
for the next 3 years is
63%.